BHK Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-863
Closed -$449K 61
2024
Q3
$449K Buy
863
+5
+0.6% +$2.67K 0.17% 50
2024
Q2
$465K Sell
858
-40
-4% -$21.1K 0.18% 46
2024
Q1
$466K Buy
898
+350
+64% +$174K 0.18% 46
2023
Q4
$258K Sell
548
-255
-32% -$118K 0.15% 50
2023
Q3
$350K Buy
+803
New +$364K 0.16% 46

Other funds holding ELV

BHK Investment Advisors's ELV Position: Q4 2024 in Review

BHK Investment Advisors sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 863 shares — an estimated $449K sold.

BHK Investment Advisors first reported a position in ELV in Q3 2023 and held it in 5 quarters. The position peaked at $466K in Q1 2024. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • BHK Investment Advisors reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • BHK Investment Advisors sold 863 Elevance Health shares in Q4 2024, an estimated $449K.
  • BHK Investment Advisors first reported a position in Elevance Health in Q3 2023 and held it in 5 quarters.
  • BHK Investment Advisors's Elevance Health position peaked at $466K in Q1 2024.
  • 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on BHK Investment Advisors's 13F filing for Q4 2024, filed 4 Feb 2025.